✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Shree Ganesh Remedies Ltd.

SGRL

Market Cap
₹780 Cr.
P/E
33.79

Shree Ganesh Remedies Ltd.

  • Shree Ganesh Remed.
  • NGL Fine-Chem
  • Acutaas Chemicals
FAQs on Shree Ganesh Remedies Ltd. Shareprice

Shree Ganesh Remed. has given better returns compared to its competitors.
Shree Ganesh Remed. has grown at ~38.21% over the last 3yrs while peers have grown at a median rate of 18.58%

Shree Ganesh Remed. is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Shree Ganesh Remed. is 33.79, while 3 year average PE is 30.72.
Also latest EV/EBITDA of Shree Ganesh Remed. is 20.61 while 3yr average is 21.5.

View FAQ's On Business
Growth Table
  • Shree Ganesh Remedies Ltd.
  • NGL Fine-Chem
  • Acutaas Chemicals
Balance Sheet
  • Shree Ganesh Remedies Ltd.
  • NGL Fine-Chem
  • Acutaas Chemicals
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Shree Ganesh Remedies Ltd.
  • NGL Fine-Chem
  • Acutaas Chemicals
Cash Flow
  • Shree Ganesh Remedies Ltd.
  • NGL Fine-Chem
  • Acutaas Chemicals
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Shree Ganesh Remedies Ltd.
  • NGL Fine-Chem
  • Acutaas Chemicals
Quarterly Results
  • Shree Ganesh Remedies Ltd.
  • NGL Fine-Chem
  • Acutaas Chemicals
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Shree Ganesh Remedies Ltd. Financials

Balance sheet of Shree Ganesh Remed. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Shree Ganesh Remed. is increasing.
Latest net debt of Shree Ganesh Remed. is ₹28.21 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹3.79 Crs.

The profit is oscillating.
The profit of Shree Ganesh Remed. is ₹23.07 Crs for TTM, ₹28.11 Crs for Mar 2024 and ₹15.18 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Shree Ganesh Remed. latest dividend payout ratio is 4.12% and 3yr average dividend payout ratio is 4.3%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech